Loading data for ABT — first visit, this takes a few seconds.

Abbott Laboratories (ABT)

NYSE: ABT · Real-Time Price · USD

110.36

-2.11 (-1.88%)

At close: Aug 31, 2026, 3:59 PM

111.95

+1.46%

Pre-market: 9:24 AM

Alert

The price, the headline numbers and the latest news, in one place.

-1.88% (1D)

Bid	110.45
Market Cap	191B
Revenue (ttm)	46.6B
Net Income (ttm)	5.4B
	0.58
	3.09
	36.42
	18.2
P/B (ttm)	3.74
P/S (ttm)	4.13
Earnings Date	Oct 14, 2026

Ask	110.3
Volume	10,631,260
Avg. Volume (20D)	11,526,684
Open	111.54
Previous Close	112.47
Day's Range	109.54 - 111.64
52-Week Range	81.97 - 137.49
Analyst	n/a
Price Target	n/a
Dividends	$2.52 (2.24%)
Ex-Dividend Date	Jul 15, 2026

About ABT

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms...

[Read more]

Industry Medical Devices

Sector Healthcare

IPO Date Mar 17, 1980

Employees 122,000

Stock Exchange NYSE

Ticker Symbol ABT

Website https://www.abbott.com

Full Company Profile

Financial Performance

In 2025, Abbott Laboratories's revenue was 44.33B, an increase of 5.67% compared to the previous year's 41.95B. Earnings were 6.52B, a decrease of -51.32%.

Financial Statements

Earnings Surprise

Abbott Laboratories has released their quarterly earnings on Jul 16, 2026:

Revenue of n/a misses estimates by $0, with -100.00% YoY decline.
EPS of 1.31 exceeds estimates by 0.03, with 3.97% YoY growth.

Next Earnings Release

Abbott Laboratories is scheduled to release its earnings on Oct 14, 2026, before market opens.
Analysts project revenue of ... Upgrade

Why Price Moved

News

13 hours ago · Investor's Business Daily

How Abbott Labs Is Embracing RFK Jr.'s Make America Healthy Again Movement

Abbott Laboratories is leaning into the Make America Healthy Movement, launching a new infant formula made with whole milk.

17 hours ago · Simply Wall St.

What Is Abbott Laboratories (ABT) Telling Investors With Its New Infant Formula?

Abbott Laboratories (NYSE:ABT) launched Similac 360 Total Care Made With Whole Milk, a commercially sterile ready-to-feed liquid infant formula made with whole milk in the U.S. The product is the firs...

17 hours ago · 24/7 Wall St.

Two Recessions Couldn’t Stop These 4 Healthcare Stocks From Raising Dividends

Two brutal recessions wiped out dividends across the market, yet a handful of healthcare companies kept raising their payouts through every quarter of both downturns. Here are the four names that made...